The stock of NantHealth Inc (NASDAQ:NH) is a huge mover today! The stock decreased 2.01% or $0.27 during the last trading session, hitting $13.15. About 775,275 shares traded hands or 495.78% up from the average. NantHealth Inc (NASDAQ:NH) has risen 6.00% since September 1, 2016 and is uptrending. It has underperformed by 4.42% the S&P500.
The move comes after 9 months negative chart setup for the $1.56B company. It was reported on Oct, 1 by Barchart.com. We have $11.97 PT which if reached, will make NASDAQ:NH worth $140.40M less.
Analysts await NantHealth Inc (NH) to report earnings on November, 8. After $-0.59 actual earnings per share reported by NantHealth Inc for the previous quarter, Wall Street now forecasts -55.93% EPS growth.
NantHealth Inc (NASDAQ:NH) Ratings Coverage
Out of 5 analysts covering Nant Health (NASDAQ:NH), 5 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Nant Health has been the topic of 5 analyst reports since June 27, 2016 according to StockzIntelligence Inc. Jefferies initiated the shares of NH in a report on Monday, June 27 with “Buy” rating. Cowen & Co initiated NantHealth Inc (NASDAQ:NH) on Monday, June 27 with “Outperform” rating. As per Monday, June 27, the company rating was initiated by Canaccord Genuity. First Analysis initiated it with “Overweight” rating and $18 target price in Monday, June 27 report. The rating was initiated by FBR Capital on Monday, June 27 with “Outperform”.
According to Zacks Investment Research, “Nant Health, LLC is a personalized healthcare company which enable improved patient outcomes and treatment decisions for critical illnesses. The company developed an adaptive learning system, CLINICS, which includes its unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets of molecular, clinical, operational and financial data points derived from novel and traditional sources. Nant Health, LLC is based in CULVER CITY, United States.”
More notable recent NantHealth Inc (NASDAQ:NH) news were published by: Fool.com which released: “Here’s Why NantHealth, Inc. Continued to Disappoint in July” on August 09, 2016, also Bloomberg.com with their article: “After NantHealth IPO, Patrick Soon-Shiong Prepares for Two More” published on June 04, 2016, Marketwatch.com published: “/quotes/zigman/3870025/realtime” on May 07, 2016. More interesting news about NantHealth Inc (NASDAQ:NH) were released by: Businesswire.com and their article: “NantHealth Announces Pricing of Initial Public Offering” published on June 01, 2016 as well as Wsj.com‘s news article titled: “NantHealth Shares Price at $14 Each in IPO” with publication date: June 02, 2016.
NH Company Profile
NantHealth, Inc., formerly Nant Health, LLC, is an evidence-based, personalized healthcare company. The Company’s systems approach to personalized healthcare applies diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with real-time biometric signal and phenotypic data to track patient outcomes and deliver medicine. The Firm has developed an integrated and adaptive Systems Infrastructure, Knowledge Platform, Provider Platform and Payor Platform known as Comprehensive Learning Integrated NantHealth Intelligent Clinical System (CLINICS), which includes its software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets molecular, clinical, operational and financial data points derived from various sources. The Company’s Systems Infrastructure includes software, middleware and hardware modules, NantOS, which organize and integrate the data streams that form the foundation of its adaptive learning system.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.